Best Medical International specializes in brachytherapy solutions, and manufactures Best® Iodine-125, Best® Palladium-103, Iridium-192 and Gold-198 seeds, along with HDR accessories, fiducial markers, Best® Brachytherapy Kits and other products. Seeds are available either loose or loaded in cartridges, needles or strands, and are available sterile or non-sterile. Best Medical can make catheters, needles, templates and applicators to meet your special needs. Best Medical International is part of a family of trusted companies now known as TeamBest® with a proven track record of innovation, quality and service in several fields such as external beam radiation therapy, brachytherapy, vascular brachytherapy, dosimetry, health physics, radiation oncology, blood irradiation, imaging and medical particle acceleration.

Valneva USA, Inc. Advancing vaccines for better lives.

CiVi Biopharma Inc. is a US-based, privately-held biopharmaceutical company, founded in 2016. The Company's research and development activities are focused on creating novel therapies for cardiovascular, metabolic and related diseases. CiVi’s innovative pipeline includes CiVi007, a long-acting PCSK9 third-generation Locked Nucleic Acid antisense molecule being developed for the treatment of hypercholesterolemia and the prevention of cardiovascular disease. In addition, the Company currently has other clinical stage development program activity aimed at treating severe liver diseases.

EndoMaster is a medical device company that is developing a novel robotic-assisted surgical system that will significantly advance current endoscopic surgeries. This will enable surgeons to perform incision-less surgery that could only be performed by open and laparoscopic surgery before.

• Led service delivery team to the successful delivery of hundreds of genomic projects per year • Leveraged project management software to implement a portfolio monitoring system resulting in 20% improvement in bioinformatic reporting turnaround time. • Consulted with sponsors, CROs, and other vendors to create Scopes of Work (SOW) and Data Transfer Agreements (DTA) aligning with study goals and clinical regulations. • Onboarded a ticket-based system to simplify client project communications and improve email response times by 15%. • Collaborated with quality and laboratory teams to align processes with GCP compliance. • Conducted clinical data review, transfer, and reconciliation tasks. • Implemented automated customer satisfaction (CSAT) surveys and monitored responses to identify targets for continual process improvement leading to increased customer success.

Nobelpharma develops medicines and medical devices with a focus on underserved patient populations and undertreated medical conditions. Visit our website at https://www.nobelpharma-us.com

𝘐𝘮𝘱𝘳𝘰𝘷𝘪𝘯𝘨 𝘏𝘦𝘢𝘭𝘵𝘩 𝘛𝘩𝘳𝘰𝘶𝘨𝘩 𝘐𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘷𝘦 𝘋𝘪𝘢𝘨𝘯𝘰𝘴𝘵𝘪𝘤𝘴. MaximBio's comprehensive in-house capabilities provide you a world-class experience and confidence in our ability to keep costs down and deliver your products in time. At MaximBio, our team of dedicated professionals with over 25 years of expertise work to create a custom-fit, full service program in state-of-the-art facilities to meet all your needs and specifications: • FDA cGMP Registered for manufacture and distribution of medical devices • Compliant with 21 CFR Part 820 for medical devices • ISO 13485:2016 Certified for manufacturing and packaging of medical devices

Founded in 2003, First Line Technology (www.firstlinetech.com) is a small business that designs and manufactures disaster preparedness and response equipment for the military, the government, and first responders. As an Out of the Box provider for emergency response equipment, First Line works directly with other manufacturers and subject matter experts to provide current solutions for emergency response missions. First Line has established itself as a leader in new product development and deployment with innovative and simple solutions. First Line prides itself on creating high-quality products that are comfortable, effective, and safe for use in an All-Hazards response.

Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. Currently approved cancer treatments are frequently ineffective, can cause undesirable side effects and provide marginal clinical benefits. The Company’s approach in developing cancer therapies utilizes its expertise in the biology of dendritic cells, which are a type of white blood cell that activate the immune system. The Company’s cancer therapies have been demonstrated in clinical trials to significantly extend both time to recurrence and survival, whilst providing a superior quality of life with no debilitating side effects when compared with current therapies. The Company’s platform technology, DCVax®, uses a patient’s own dendritic cells, the starter engine of the immune system. The dendritic cells are extracted from the body, loaded with tumor biomarkers or ‘‘antigens’’, thereby creating a personalized therapeutic vaccine. Injection of these cells back into the patient initiates a potent immune response against cancer cells, resulting in delayed time to progression and prolonged survival. The Company’s lead product candidate is DCVax®-Brain which targets Glioblastoma Multiforme (‘‘GBM’’), the most lethal form of brain cancer. DCVax®-Brain has entered a Phase II FDA-allowed clinical trial, which is designed and powered as a pivotal trial (i.e. a trial from which a company may go directly to product approval). Following this trial, the Company anticipates filing a biologic license application (or ‘‘BLA’’) with the FDA for DCVax®-Brain. DCVax®-Prostate, which targets hormone independent (i.e. late stage) prostate cancer, has also been cleared by the FDA to commence a Phase III clinical trial, which is also designed and powered as a pivotal trial.

Imagilin® Technology, LLC is a biotechnology company based in Frederick, Maryland, USA. Since 2003, we have been committed to developing innovative technologies and producing nutraceutical products with an emphasis on the company's patented plant-based probiotics to enhance and support human and animal health. We are rapidly expanding throughout the United States and Asian markets with comprehensive involvement in basic research, as well as clinical studies worldwide for all our products. We are dedicated to revolutionizing plant-based products that ensure ethical performance and provide greater value to all of our members and the environment. We collaborate with renowned institutions worldwide to ensure the effectiveness and quality of our products. Imagilin® Technology, LLC is well recognized for its continuous innovation in developing cleaner, healthier supplements that are safe,effective, and held to a higher standard. Currently, our probiotic technology platform and intellectual properties are protected by 8 issued patents and several pending patents in order to support our nutraceutical developments. We market the patented probiotic strain Pediococcus Acidilactici NRRL B-50517 to companies seeking to incorporate this natural ingredient into their dietary supplements and food products. Finished probiotic goods are also readily available to the public as dietary supplements for humans and animals through a channel of retail stores and websites. Find out where you can purchase: https://www.imagilin.com/where-to-buy.

We are a boutique custom formulator and manufacturer of prestige natural products. From skin, body and hair care, to color cosmetics, Pet care, and household goods, we invite you to create something special that inspires and delights. This is where science meets creativity. HFB employs the intelligence of superior organic botanicals and sublime natural ingredients. We’ll work together to artfully craft luxurious formulas and ultimately, your brand vision. Our Brand & Business Strategy Lab develops and activates your brand in a modern, personal way. We combine classic brand strategy and account planning with digital strategy plus data and user research, to uncover your brand’s true capability. Our inspirational approach goes into design, products, content, technology, services, and campaigns, defining personal experiences that consumers take pleasure in. We provide these unique and advanced services for an array of clients – from small independently held companies, to prestige mass retailers and multinational conglomerates.